← All stocks

NOVAVAX INC

NVAX No buying or selling

CIK 0001000694 #2303 in the set updated 18 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

15 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jacobs John C

President and CEO

—

225,680

0.1368%

$1.81M

—

O'Hara Elaine

EVP, Chief Strategy Officer

—

134,642

0.0816%

$1.08M

+846.5%

Kelly James Patrick

EVP, CFO and Treasurer

—

130,599

0.0792%

$1.04M

+671.9%

Casey Mark J

EVP, Chief Legal Officer

—

90,067

0.0546%

$720.54K

—

MOTT DAVID M

Director

—

79,770

0.0484%

$638.16K

+58.1%

DOUGLAS RICHARD

Director

—

73,220

0.0444%

$585.76K

+66.7%

Trizzino John

President and COO

—

68,061

0.0413%

$544.49K

+140.4%

YOUNG JAMES F

Director

—

51,760

0.0314%

$414.08K

−16.2%

Alton Gregg H

Director

—

47,685

0.0289%

$381.48K

+216.0%

Rodgers Richard J

Director

—

47,370

0.0287%

$378.96K

+352.4%

MCGLYNN MARGARET G

Director

—

44,468

0.0270%

$355.74K

+236.6%

King Rachel K.

Director

—

44,070

0.0267%

$352.56K

+132.9%

Draghia-Akli Ruxandra

EVP, Research & Development

—

23,563

0.0143%

$188.50K

—

Newton Charles W.

Director

—

9,520

0.0058%

$76.16K

—

Shiver John W.

Director

—

7,947

0.0048%

$63.58K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,088,986

History held since 21 Sep 2016